MAPT and dementia: And in support of assessing fasudil further as a potential treatment for AD not only does the drug to reduce Aβ production from neuronally expressed human APP42, supporting of our own data here, but it has also been shown to ameliorate tau pathology, albeit in models of other forms of dementia, that like AD, include pathological tau aggregates43.